- Home
- EVGN vs BRTX Comparison
EVGN vs BRTX Comparison
Compare EVGN & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- BRTX
- Stock Information
- Founded
- EVGN 1999
- BRTX 1997
- Country
- EVGN Israel
- BRTX United States
- Employees
- EVGN N/A
- BRTX N/A
- Industry
- EVGN Agricultural Chemicals
- BRTX Managed Health Care
- Sector
- EVGN Industrials
- BRTX Health Care
- Exchange
- EVGN Nasdaq
- BRTX Nasdaq
- Market Cap
- EVGN 10.9M
- BRTX 10.0M
- IPO Year
- EVGN N/A
- BRTX N/A
- Fundamental
- Price
- EVGN $1.18
- BRTX $1.22
- Analyst Decision
- EVGN Strong Buy
- BRTX
- Analyst Count
- EVGN 1
- BRTX 0
- Target Price
- EVGN $3.50
- BRTX N/A
- AVG Volume (30 Days)
- EVGN 50.9K
- BRTX 310.4K
- Earning Date
- EVGN 11-20-2025
- BRTX 11-12-2025
- Dividend Yield
- EVGN N/A
- BRTX N/A
- EPS Growth
- EVGN N/A
- BRTX N/A
- EPS
- EVGN N/A
- BRTX N/A
- Revenue
- EVGN $9,444,000.00
- BRTX $383,400.00
- Revenue This Year
- EVGN N/A
- BRTX $232.67
- Revenue Next Year
- EVGN $12.35
- BRTX $52.92
- P/E Ratio
- EVGN N/A
- BRTX N/A
- Revenue Growth
- EVGN 42.25
- BRTX 1.70
- 52 Week Low
- EVGN $0.95
- BRTX $1.10
- 52 Week High
- EVGN $2.42
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- EVGN 44.25
- BRTX 33.04
- Support Level
- EVGN $1.15
- BRTX $1.10
- Resistance Level
- EVGN $1.25
- BRTX $1.37
- Average True Range (ATR)
- EVGN 0.06
- BRTX 0.09
- MACD
- EVGN -0.00
- BRTX -0.03
- Stochastic Oscillator
- EVGN 33.35
- BRTX 30.09
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.